JNJ · Johnson & Johnson
AI read · Good for JNJ
The AI's read
The stronger patient responses give J&J evidence that ICOTYDE may help people with psoriatic arthritis. The report also describes everyday benefits for nipocalimab users. But nipocalimab’s Phase 3 study has only begun, so its results are not yet known.